| RS2524992538 |
SLC2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Encephalopathy due to GLUT1 deficiency, Childhood onset GLUT1 deficiency syndrome 2 |
| RS2524992555 |
SLC2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Encephalopathy due to GLUT1 deficiency, GLUT1 deficiency syndrome 1 |
| RS2524992657 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS2524992866 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS2524993821 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS2524994181 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS2524994322 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS2524994412 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS2524994638 |
SELENON
|
Health Risk |
Pathogenic |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS2524994791 |
SELENON
|
Health Risk |
Pathogenic |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS2524994962 |
SDHB
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2524994983 |
SDHB
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2524995090 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 4, Pheochromocytoma |
| RS2524995128 |
SDHB
|
Health Risk |
Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 4, Pheochromocytoma/paraganglioma syndrome 4 |
| RS2524997284 |
SLC2A1
|
Health Risk |
Pathogenic |
— |
| RS2524997294 |
SLC2A1
|
Health Risk |
Pathogenic |
Encephalopathy due to GLUT1 deficiency, Encephalopathy due to GLUT1 deficiency |
| RS2524997437 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS2524997712 |
SLC2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2524997940 |
SLC2A1
|
Health Risk |
Likely pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS2524997975 |
SLC2A1
|
Health Risk |
Likely pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS2524998256 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS2524998344 |
SLC2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2524998439 |
SLC2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS2524998969 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS2524999169 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS2524999400 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS2524999421 |
SLC2A1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2524999434 |
SLC2A1
|
Health Risk |
Likely pathogenic |
Dystonia 9, Dystonia 9 |
| RS2524999574 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS2524999660 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS2524999769 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS2525003715 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2525003739 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 4, Pheochromocytoma |
| RS2525003842 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2525004018 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 4, Pheochromocytoma |
| RS2525004143 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Pheochromocytoma |
| RS2525004176 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Gastrointestinal stromal tumor |
| RS2525004214 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Gastrointestinal stromal tumor |
| RS2525004224 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2525004279 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma, Gastrointestinal stromal tumor |
| RS2525004332 |
SDHB
|
Health Risk |
Pathogenic |
Renal cell carcinoma, Renal cell carcinoma |
| RS2525005084 |
SELENON
|
Health Risk |
Likely pathogenic |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS2525008654 |
SDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Pheochromocytoma, Gastrointestinal stromal tumor |
| RS2525008725 |
SDHB
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Gastrointestinal stromal tumor |
| RS2525010444 |
DDR2
|
Health Risk |
Pathogenic |
— |
| RS2525015022 |
COL11A1
|
Health Risk |
Pathogenic |
COL11A1-related disorder, COL11A1-related disorder |
| RS2525016020 |
COL11A1
|
Health Risk |
Pathogenic |
— |
| RS2525016047 |
COL11A1
|
Health Risk |
Pathogenic |
— |
| RS2525017627 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma, Pheochromocytoma/paraganglioma syndrome 4 |
| RS2525017788 |
SDHB
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma/paraganglioma syndrome 4 |
| RS2525018148 |
SDHB
|
Health Risk |
Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 4, Pheochromocytoma/paraganglioma syndrome 4 |
| RS2525020268 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Pheochromocytoma/paraganglioma syndrome 4 |
| RS2525020453 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 4, Pheochromocytoma |
| RS2525020788 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS2525020920 |
SDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS2525020995 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Pheochromocytoma/paraganglioma syndrome 4 |
| RS2525027053 |
SPTA1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 3, Hereditary spherocytosis type 3 |
| RS2525031517 |
NFIA
|
Health Risk |
Likely pathogenic |
Brain malformations with or without urinary tract defects, Brain malformations with or without urinary tract defects |
| RS2525032431 |
SPTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2525035112 |
SLC2A1
|
Health Risk |
Likely pathogenic |
SLC2A1-related disorder, SLC2A1-related disorder |
| RS2525035843 |
DDR2
|
Health Risk |
Pathogenic |
— |
| RS2525037609 |
SNX27
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS2525040830 |
CASQ1
|
Health Risk |
Pathogenic |
Myopathy with tubular aggregates, Myopathy with tubular aggregates |
| RS2525047102 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS2525047217 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2525047746 |
DMD
|
Health Risk |
Likely pathogenic |
— |
| RS2525047957 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2525049766 |
SPTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2525049882 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2525049931 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2525050898 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2525053134 |
KCND3
|
Health Risk |
Pathogenic |
— |
| RS2525053501 |
KCND3
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 19/22, Spinocerebellar ataxia type 19/22 |
| RS2525053579 |
KCND3
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 19/22, Spinocerebellar ataxia type 19/22 |
| RS2525054281 |
ALG13
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 36 |
| RS2525059708 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 4, Pheochromocytoma |
| RS2525059744 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 4, Pheochromocytoma |
| RS2525059780 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma, Gastrointestinal stromal tumor |
| RS2525060115 |
SDHB
|
Health Risk |
Likely pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS2525060252 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Pheochromocytoma |
| RS2525063877 |
COL11A1
|
Health Risk |
Pathogenic |
COL11A1-related disorder, COL11A1-related disorder |
| RS2525071082 |
SPTA1
|
Health Risk |
Likely pathogenic |
SPTA1-related disorder, SPTA1-related disorder |
| RS2525073526 |
ADCY10
|
Health Risk |
Pathogenic |
— |
| RS2525078899 |
SPTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2525082757 |
SDHB
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Pheochromocytoma |
| RS2525082838 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2525083200 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Pheochromocytoma/paraganglioma syndrome 4 |
| RS2525084740 |
SLC2A1;SLC2A1-DT
|
Health Risk |
Pathogenic |
Childhood onset GLUT1 deficiency syndrome 2, Childhood onset GLUT1 deficiency syndrome 2 |
| RS2525088360 |
SLC16A1
|
Health Risk |
Pathogenic |
SLC16A1-related disorder, SLC16A1-related disorder |
| RS2525089647 |
PIK3CD
|
Health Risk |
Pathogenic |
Immunodeficiency 14, Immunodeficiency 14 |
| RS2525092495 |
SPTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2525100006 |
BBS2
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2525104200 |
SPTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2525109111 |
COL11A1
|
Health Risk |
Pathogenic |
— |
| RS2525109189 |
NFIA
|
Health Risk |
Pathogenic/Likely pathogenic |
Brain malformations with or without urinary tract defects, Brain malformations with or without urinary tract defects |
| RS2525109250 |
COL11A1
|
Health Risk |
Likely pathogenic |
Stickler syndrome type 2, Marshall syndrome |
| RS2525111885 |
SPTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2525112539 |
SF3B4
|
Health Risk |
Likely pathogenic |
SF3B4-related disorder, SF3B4-related disorder |
| RS2525112967 |
COL11A1
|
Health Risk |
Pathogenic |
— |
| RS2525117956 |
COL11A1
|
Health Risk |
Pathogenic |
— |